By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Dec 30, 2022/Test & Measure
The EuroQol 5 Dimension 5 Level (EQ-5D-5L) is a self-report survey that measures quality of life across 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is scored on a 5-level severity ranking that ranges from "no problems" through "extreme
Oct 9, 2024/Test & Measure
The Hip Outcome Score (HOS) assesses self-reported functional status of those with musculoskeletal hip disorders.
Mar 15, 2021/Review
After six weeks, study participants using an exercise and education app showed significant progress over their "usual care" counterparts.
Jun 18, 2019/News
"Any movement-related profession—personal trainers, athletic trainers, dance therapists, yoga instructors—who can observe impairments such as a weak muscle can try to fix it," said Beth Fisher, PT, PhD, FAPTA, in delivering the 24th John H. P. Maley Lecture on June 14 at Combined Sections Meeting. However,
Sep 21, 2021/Article
Treatment of bicyclists has a few challenges that typically are not taught in physical therapist education programs.
Jun 16, 2022/Test & Measure
The EPIC Lift Capacity test (ELC) is used to evaluate lifting capacity through different vertical ranges necessary to carry out the occupational demands required for lifting on an occasional or frequent basis.
Jun 1, 2025/Column
An unexpected reunion between a PT and a patient 59 years later reveals the enduring power of human connection in healing.
Nov 13, 2025/Review
In this review: Factors related to reversal of prediabetes in patients from a cardiovascular risk program during 2019- 2023 (BMC Research, open access). The Message In this study, patients with prediabetes — defined as elevated glycemia levels not meeting diagnostic criteria for diabetes — enrolled in
Sep 7, 2022/Test & Measure
Oct 31, 2021/Test & Measure
The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1